|
業務類別
|
Medical Devices |
|
業務概覽
|
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same. |
| 公司地址
| 1220 Concord Avenue, Suite 600, Concord, CA, USA, 94520 |
| 電話號碼
| +1 925 288-6000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.cerus.com |
| 員工數量
| 275 |
| Mr. Vivek K. Jayaraman |
Chief Operating Officer |
美元 548.40K |
23/04/2025 |
| Ms. Chrystal Jensen |
Chief Legal Officer, General Counsel and Secretary |
美元 468.53K |
23/06/2025 |
| Mr. Richard J. Benjamin |
Chief Medical Officer |
美元 493.08K |
23/04/2025 |
| Mr. Kevin D. Green |
Vice President, Finance, Chief Financial Officer and Principal Accounting Officer |
美元 488.12K |
02/03/2026 |
| Mr. William M. Greenman |
Chairman of the Board, President and Chief Executive Officer |
美元 770.00K |
02/03/2026 |
|
|
| Mr. Eric H. Bjerkholt, M.B.A. |
Independent Director |
02/03/2026 |
| Mr. Timothy L. Moore |
Independent Director |
23/01/2026 |
| Ms. Jami Dover Nachtsheim |
Independent Director |
02/03/2026 |
| Dr. Hua Shan, M.D.,PhD |
Independent Director |
02/03/2026 |
| Ms. Ann Lucena |
Independent Director |
02/03/2026 |
| Dr. Frank R. Witney,, PhD |
Lead Independent Director |
02/03/2026 |
| Mr. William M. Greenman |
Chairman of the Board, President and Chief Executive Officer |
02/03/2026 |
| Mr. Dean Gregory |
Independent Director |
02/03/2026 |
|
|
|
|
